|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$86,043,464 |
|
|
Indirect Value
|
$13,186,326,474 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,272,369,938 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
9
|
6
|
Stock
price went up :
|
0
|
6
|
Stock
price went down : |
9
|
0
|
|
|
|
Gain/Loss Ratio : |
-9.0
|
6.0
|
Percentage
Gain/Loss : |
-27.9%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 19 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$2,382,705 |
I/I |
142,938 |
1,017,895 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$199,767 |
I/I |
11,984 |
72,942 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$6,283,985 |
I/I |
376,975 |
2,822,532 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-22 |
4 |
B |
$16.67 |
$16,003 |
I/I |
960 |
193,104 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$432,557 |
I/I |
26,373 |
1,044,268 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$36,264 |
I/I |
2,211 |
75,153 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$1,140,774 |
I/I |
69,553 |
2,892,085 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$2,903 |
I/I |
177 |
193,281 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$33,769 |
I/I |
2,066 |
77,219 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$1,062,827 |
I/I |
65,025 |
2,957,110 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$2,713 |
I/I |
166 |
193,447 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$402,984 |
I/I |
24,655 |
1,068,923 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$57,082 |
I/I |
3,514 |
80,733 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$680,782 |
I/I |
41,909 |
1,110,832 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$4,581 |
I/I |
282 |
193,729 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$1,795,466 |
I/I |
110,529 |
3,067,639 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-29 |
4 |
B |
$16.39 |
$47,110 |
I/I |
2,875 |
83,608 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-29 |
4 |
B |
$16.39 |
$561,850 |
I/I |
34,288 |
1,145,120 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-29 |
4 |
B |
$16.39 |
$3,769 |
I/I |
230 |
193,959 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-29 |
4 |
B |
$16.39 |
$1,481,771 |
I/I |
90,428 |
3,158,067 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-30 |
4 |
B |
$16.44 |
$81,953 |
I/I |
4,984 |
1,150,104 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-30 |
4 |
B |
$16.44 |
$543 |
I/I |
33 |
193,992 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-30 |
4 |
B |
$16.44 |
$216,097 |
I/I |
13,142 |
3,171,209 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-30 |
4 |
B |
$16.44 |
$6,873 |
I/I |
418 |
84,026 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-05 |
4 |
B |
$19.50 |
$1,899,293 |
I/I |
96,863 |
3,268,072 |
2.25 |
- |
|
1397 Records found
|
|
Page 19 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|